BMO Capital Upgrades Regeneron Pharma (REGN) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St futures rise as AI stocks catch their breath; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops over 4% on hopes of progress in talks on ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| Regeneron (NASDAQ: REGN) | Delayed: 927.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $927.89 | 52 Week High | $592.36 | |||
| Open | $927.89 | 52 Week Low | $325.35 | |||
| Day High | $927.89 | P/E | 243.54 | |||
| Day Low | $927.89 | EPS | $3.81 | |||
| Volume | 776 | |||||
